Investor Debt Information
Credit Ratings and Debt
|Senior Unsecured Notes||Standard & Poor's Ratings Services||Moody's Investor Services|
|Bank Credit Facility||BBB-||Not Rated|
Debt and Credit Facilities 1
|Term (Years)||Coupon/Rate||Amount ($Mills)||Maturity|
|Senior Unsecured Notes||5||2.875% Fixed||$600||10/15/2018|
|Bank Credit Facility 2||5||Libor Based Floating Rate||$750||7/18/2019|
1 For more information please refer to the Company's 10K and 10Q filings
2 $750 million Amount is total amount currently available. Refer to the Companies 10K and 10-Q filings for amounts drawn and outstanding
Ratings are not a recommendation to buy, sell or hold securities and may be changed, suspended or withdrawn at any time by the assigning rating agency.
Each rating should be evaluated independently of the others. Detailed explanations of the ratings may be obtained from the rating agencies.
Edwards Lifesciences makes no representations or warranties with respect to the rating information above and takes no responsibility for supplementing, updating or correcting any such information.
David K. Erickson
Vice President, Investor Relations
phone: (949) 250-6826
Sr. Manager, Investor Relations
phone: (949) 250-2752